Print Preview Area

Validation of the patient benefit index for the assessment of patient-relevant benefit in the treatment of psoriasis
Archives of Dermatological Research, 06/26/2012

Feuerhahn J et al. – The Patient Benefit Index (PBI) showed convergent validity regarding the quality of life, psoriasis area and severity index, and two single questions on treatment benefit used in the longitudinal study. The PBI is a suitable instrument for the assessment of patient–reported benefit in the treatment of psoriasis.

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Stay current on the latest literature, research and clinical news
Get special communications and offers from MDLinx and our sponsors
Receive invitations to paid market research

View Samples and Register

Stay current - Media Tool

Newsletter

RSS

Facebook

Receive free subspecialty
"5-minute updates" via email

Send the E-mail Newsletter to a Colleague

♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦

♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦

♦ Follow Us on Facebook

Search the latest
Nurse Practitioner Jobs
@MDLinx Career Center
View the full listing of nursing jobs

Enter your email address and your password will be sent to you.
Email:

E-mail:
Password:
	Remember me Forgot your password?

Validation of the patient benefit index for the assessment of patient-relevant benefit in the treatment of psoriasis Archives of Dermatological Research, 06/26/2012

Validation of the patient benefit index for the assessment of patient-relevant benefit in the treatment of psoriasis
Archives of Dermatological Research, 06/26/2012